Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
Hand-out
Press Releases
Samsung Biologics  
January 22, 2025

Samsung Biologics reports fourth quarter and fiscal year 2024 financial results

Recorded Q4'24 consolidated revenue of KRW 1.26 trillionRecorded FY'24 consolidated revenue of KRW 4.55 trillionPoised for further growth with expanded capacity and new service offerings

logo salamanca press

Salamanca Press

Local & Social